Literature DB >> 2357825

Age and sex distribution of alkaline phosphatase isoenzymes by agarose electrophoresis.

V O Van Hoof1, M F Hoylaerts, H Geryl, M Van Mullem, L G Lepoutre, M E De Broe.   

Abstract

We separated isoenzymes of alkaline phosphatase (ALP; EC 3.1.3.1) in 1383 sera of normal individuals (ages 4-65 years) by agarose electrophoresis with the Isopal system (Analis). As expected, the predominant isoenzyme in children was of bone origin, and almost all (99%) of the children had low activities of a second bone fraction, "bone variant" ALP. The "bone variant" disappeared after age 17 in girls and after age 20 in boys. The highest (median) bone ALP activity was reached at age 9 to 10 in girls and at age 13 to 14 in boys, followed by a gradual decline in girls and a steep decline in boys. During adulthood, activity of the bone fraction was constant and no significant differences were observed between sexes, neither for bone nor for liver ALP activity. The latter remained almost unchanged throughout life. We observed no high-Mr ALP activity in children, whereas sera from 60% of the adults contained low activities of high-Mr ALP. Intestinal ALP (soluble form) and "intestinal variant" ALP (hydrophobic form) were frequently present, in 21% and 37% of all samples, respectively. No significant differences were observed between age groups and sexes for the intestinal isoenzymes.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2357825

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  16 in total

1.  Alkaline Phosphatase: A Biomarker of Cardiac Function in Pediatric Patients.

Authors:  Elizabeth S Makil; Xinyu Tang; Elizabeth A Frazier; R Thomas Collins
Journal:  Pediatr Cardiol       Date:  2017-02-09       Impact factor: 1.655

2.  Biochemical markers of bone turnover: part I: biochemistry and variability.

Authors:  Markus J Seibel
Journal:  Clin Biochem Rev       Date:  2005-11

3.  Impact of Early Versus Late Diuretic Exposure on Metabolic Bone Disease and Growth in Premature Neonates.

Authors:  Lucas E Orth; Keliana L O'Mara
Journal:  J Pediatr Pharmacol Ther       Date:  2018 Jan-Feb

4.  The significance of routine laboratory analyses in the assessment of teenage girls with eating disorders and weight loss.

Authors:  I Swenne
Journal:  Eat Weight Disord       Date:  2004-12       Impact factor: 4.652

5.  Functional high-intensity training improves pancreatic β-cell function in adults with type 2 diabetes.

Authors:  Stephan Nieuwoudt; Ciarán E Fealy; Julie A Foucher; Amanda R Scelsi; Steven K Malin; Mangesh Pagadala; Michael Rocco; Bartolome Burguera; John P Kirwan
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-05-16       Impact factor: 4.310

Review 6.  The two faces of growth: benefits and risks to bone integrity.

Authors:  A M Parfitt
Journal:  Osteoporos Int       Date:  1994-11       Impact factor: 4.507

7.  Serum alkaline phosphatase reflects post-Fontan hemodynamics in children.

Authors:  Alvin J Chin; P Stephens; E Goldmuntz; M B Leonard
Journal:  Pediatr Cardiol       Date:  2008-08-07       Impact factor: 1.655

8.  Alkaline phosphatase isozymes of serum and urine and urinary protein in young men before and after running 3 km.

Authors:  T Sato; H Sugimoto; W X Yan; K Endo; M Yamamoto
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1994

9.  Endoscopic retrograde cholangiography for pediatric choledocholithiasis: Assessing the need for endoscopic intervention.

Authors:  Douglas S Fishman; Bruno P Chumpitazi; Isaac Raijman; Cynthia Man-Wai Tsai; E O'Brian Smith; Mark V Mazziotti; Mark A Gilger
Journal:  World J Gastrointest Endosc       Date:  2016-06-10

Review 10.  Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of the Belgian Bone Club.

Authors:  P Bergmann; J-J Body; S Boonen; Y Boutsen; J-P Devogelaer; S Goemaere; J-M Kaufman; J-Y Reginster; V Gangji
Journal:  Int J Clin Pract       Date:  2009-01       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.